Novartis (Intellectual Property Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Novartis (Intellectual Property Rights) General Information

Description

Portfolio of trademark and intellectual property rights of the antidepressant drug Pamelor. Pamelor is an antidepressant drug whose active ingredient is Nortriptyline Hydrochloride and is approved by the Food and Drug Administration (FDA) of the United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Brazil
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Intellectual Property Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Intellectual Property Rights)‘s full profile, request access.

Request a free trial

Novartis (Intellectual Property Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Intellectual Property Rights)‘s full profile, request access.

Request a free trial

Novartis (Intellectual Property Rights) FAQs

  • Where is Novartis (Intellectual Property Rights) headquartered?

    Novartis (Intellectual Property Rights) is headquartered in Brazil.

  • What industry is Novartis (Intellectual Property Rights) in?

    Novartis (Intellectual Property Rights)’s primary industry is Buildings and Property.

  • Is Novartis (Intellectual Property Rights) a private or public company?

    Novartis (Intellectual Property Rights) is a Private company.

  • What is Novartis (Intellectual Property Rights)’s current revenue?

    The current revenue for Novartis (Intellectual Property Rights) is .

  • Who are Novartis (Intellectual Property Rights)’s investors?

    Novartis has invested in Novartis (Intellectual Property Rights).

  • When was Novartis (Intellectual Property Rights) acquired?

    Novartis (Intellectual Property Rights) was acquired on 22-Dec-2017.

  • Who acquired Novartis (Intellectual Property Rights)?

    Novartis (Intellectual Property Rights) was acquired by Cellera Farmacêutica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process